Related Experiment Video
Updated: Apr 4, 2026

Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury
Published on: September 7, 2018
Steroid-responsive meningitis-arteritis in a dog presented with marked cardiac dysfunction and a hypercoagulable
Jessica Lam1, Daniel Moreno1, Mathieu Paulin1
1Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan (Lam, Gu, Carr, Taylor); Small Animal Internal Medicine, Pulse Veterinary Specialists and Emergency, Sherwood Park, Alberta (Moreno); Small Animal Internal Medicine, Canada West Veterinary Specialists, Vancouver, British Columbia (Paulin).
Abstract:
Canine steroid-responsive meningitis-arteritis (SRMA) is an immune-mediated inflammatory disorder targeting the leptomeninges and associated vasculature with systemic inflammation and occasionally with mild systolic dysfunction and cardiac arrhythmias. Hypercoagulability has not been previously documented in dogs with SRMA, despite increases in inflammatory markers. This case report describes a 6-month-old female Australian heeler dog with acute progressive pyrexia and cervical hyperesthesia. Notable findings included marked decreased cardiac contractility and hypercoagulability determined via viscoelastic coagulation monitor and rotational thromboelastographic analysis. The SRMA was diagnosed based on clinical findings, cerebrospinal fluid analysis, magnetic resonance imaging, elimination of infectious causes of meningitis, and resolution of abnormalities after treatment with immunosuppressive medications. This is the first report describing severe systolic dysfunction and hypercoagulability in a dog with SRMA. The findings support routinely evaluating cardiac function and coagulation in dogs with SRMA and considering treatment with antithrombotic drugs when warranted. Key clinical message: It is important to consider cardiovascular and coagulation complications in dogs with SRMA. Dogs exhibiting atypical findings, such as arrythmia or unexplained clinical deterioration, may require further diagnostic workup. Early identification of these complications could necessitate the use of antithrombotic drugs and prompt monitoring of cardiac function to optimize patient outcomes.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Myocarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Pericarditis III: Medical Management
Myocarditis I: Introduction
Mitral Stenosis I: Introduction

